July 20, 2007 - Dune Medical Devices (Caesarea, Israel) received the 2007 Frost & Sullivan European Technology Innovation of the Year Award in surgical oncology for its novel intraoperative breast cancer probe. Using Radio Frequency (RF) Spectroscopy, the device provides surgeons with the malignancy status of breast cancer margins in real-time.
The Dune hand-held probe reportedly holds significant promise to reduce re-excision procedures, improve patient outcomes and minimize surgical expenses.
“Dune's real-time tissue probe and portable console have the potential to satisfy a major unmet surgical oncology need,” noted Frost & Sullivan Research Director Girish Solanki. “The device provides doctors with simple, real-time determination of margin malignancy status at the desired locus while the patient is still in the operating room. It helps improve surgical accuracy, allowing doctors to meet procedure goals more easily without the need for a second surgery.”
"Today, breast conservation surgery aims to excise tumors completely, along with a rim of surrounding healthy tissue. However, determining the status of this tissue is difficult, and a large number of women must undergo a re-excision to achieve desired surgical results. This is because an accurate and reliable method for accessing margin status intraoperatively has not existed until now. The Dune probe fills an important need," added Solanki.
In a recent study the Dune probe detected 86 percent of positive tumor margins that were otherwise missed by current standard of care, potentially allowing surgeons to reshave the tumor cavity and eliminate an additional surgery. In a second study, the device identified 20 out of 21 DCIS sites as verified by post-operative pathology reports.
"Among the probe's multiple advantages are intraoperative detection of positive resection margins in breast conservation surgery and the quantification of dozens of measurement points within minutes, along with simple operation supporting current breast surgical workflow,” said Solanki.
For more information: www.dunemedical.com
September 14, 2023 
